Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
europe top stories
7
×
life sciences
national blog main
europe blog main
clinical trials
fda
national top stories
san francisco top stories
boston blog main
boston top stories
eli lilly
indiana blog main
indiana top stories
national
new york top stories
san francisco blog main
cancer
new york blog main
novartis
abbvie
amgen
boehringer ingelheim
boulder/denver blog main
boulder/denver top stories
cancer drugs
detroit blog main
detroit top stories
europe
genentech
raleigh-durham blog main
raleigh-durham top stories
roche
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
What
drug
7
×
fda
medicine
approval
patients
cancer
carries
designed
marketing
therapy
weight
acquisitions
address
alkermes
amgen
amgen’s
antipsychotic
approved
approves
atrophy
benefits
bid
biggest
bio
blueprint
boehringer
build
buy
caveats
ceo
certain
commonly
company’s
daily
daniel
debut
developed
diabetes
dyne’s
effect
Language
unset
Current search:
drug
×
" europe top stories "
×
@xconomy.com
3 years ago
FDA Panel Vote Weighs in Favor of Alkermes Psyche Drug, With Caveats
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
4 years ago
FDA Rejects Boehringer Ingelheim, Eli Lilly Drug for Type 1 Diabetes
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
4 years ago
Amgen’s Osteoporosis Drug Wins European Nod, With a Heart Warning